Symptoms from repeated intentional and unintentional head impact in soccer players
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 15, 2016
- Accepted in final form November 7, 2016
- First Published February 1, 2017.
Article Versions
- Previous version (February 1, 2017 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Walter F. Stewart, PhD, MPH,
- Namhee Kim, PhD, PhD,
- Chloe S. Ifrah, BA,
- Richard B. Lipton, MD,
- Tamar A. Bachrach, BA,
- Molly E. Zimmerman, PhD,
- Mimi Kim, ScD and
- Michael L. Lipton, MD, PhD
- Walter F. Stewart, PhD, MPH,
NONE
NONE
NONE
Neuroepidemiology, associate editor, 2011-2014
NONE
NONE
NONE
1) Amgen, outcomes research, $8,950 2) Genentech, translational research, $1500 3) Health Affairs, $750
NONE
NONE
NONE
NONE
NHLBI, R01 HL116832, Heart Failure, PI NIH, R01 NS 082432, Head Injury in Soccer, Consultant NIDDK, R01 DK 082551, Bladder Control, Co-I
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Namhee Kim, PhD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chloe S. Ifrah, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH Grant R01 310567 since July 2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Richard B. Lipton, MD,
Allergan, e-Neura, Merck
NONE
Serve as consultant, advisory board member or received honoraria from: Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Boston Scientific, CoLucid, Dr. Reddys, Electrocore, Eli Lilly, eNeura Therapeutics, Glaxo Inc. (formerly Novartis), Merck, Pfizer, Teva, Vedanta
NONE
NONE
Wolff's Headache, 8th Edition, Oxford University Press; Informa
NONE
Serve as consultant, advisory board member or received honoraria from: Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Boston Scientific, CoLucid, Dr. Reddys, Electrocore, Eli Lilly, eNeura Therapeutics, Glaxo Inc. (formerly Novartis), Merck, Pfizer, Teva, Vedanta
NONE
NONE
NONE
Bristol Myers Squibb Early Detection of Alzheimer's Disease June 2010 - present Vedanta Research Migraine epidemiology and Progression June 2010 - present Boston Scientific Occipital Nerve Stimulation in Migraine March 2013 - present ElectroCore Vagal Nerve Stimulation for Migraine and Cluster May 2013 Novartis Sleep and Migraine September 2012 - present Allergan Botox in Migraine April 2012 - present Allergan Chronic Migraine Epidemiology and Outcome Study January 2012 - present
P01 AG03949 4/1/11-3/31/16 Einstein Aging Study Role: Principle Investigator 1KL2RR025749 07/01/09-06/30/13 Clinical and Translational Science Award (CTSA) Research Career Development Award Role: Primary Mentor R01AG022374 8/1/10-7/31/15 Biomarkers in Early Alzheimer?s Disease Role: Investigator R01AG034119 8/1/10-7/31/15 Two Preclinical Latent Scores to Predict Occurrence of DAT Role: PI, Einstein Site R01AG012101 9/15/10-7/31/15 MRI Progression Markers of Cognitive Decline in the Elderly Role: PI, Einstein Site 1R01AG039409-01 Stress, Unconstructive Repetitive Thought & Cognitive Aging 4/1/11-3/31/16 Role: PI, Einstein Site 1R01AG038651-01A1 Role of impaired cognitive states & risk factors in conversion to mixed dementias 9/1/11-8/31/16 Role: PI, Einstein Site 1U10NS077308- 01 9/30/11-8/31/18 Einstein Center for Excellence for Clinical Trials in Neuroscience Role: PI NIH 4/1/12-3/31/17 Behavioral Weight Loss as a Treatment for Migraine in Obese Women Role: Investigator NIH 1R01AG042595 - 01A1 Stress, cognition, repetitive unconstructive thoughts and inflammatory markers Role: Investigator
NONE
S & L Marx Foundation Alzheimer's Research Czap Foundation Alzheimer's Research
eNeura Pharma
NONE
Oxford University Press; Baxter Publishing
NONE
NONE
NONE
- Tamar A. Bachrach, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Molly E. Zimmerman, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Funded as co-investigator by NIH grants # P01AG003949 (PI: R. B. Lipton) and R01NS082432 (P.I.: M. L. Lipton)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mimi Kim, ScD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH UH2AR067689-02 (Buyon, Putterman, Tuschl) 09/24/2014 ? 05/31/2019 0.60 calendar months Biostatistician P30 CA01330-35 (Goldman) 07/01/2013 ? 06/30/2018 1.32 calendar months NIH $3,585,248 Cancer Center Support Grant Type: Center Grant; July, 2007 ? June, 2012 Role: Dr. Kim directs the Biostatistics Shared resource which provides statistical expertise and collaboration to investigators in the Albert Einstein Cancer Center. 1UL1RR025750-01 (Shamoon) 05/01/2013 ? 04/30/2018 1.62 calendar months NIH $2,607,087 Clinical and Translational Science Award The mission of the Institute for Clinical and Translational Research is to enhance clinical and translational research by promoting multidisciplinary collaboration, addressing translational ?blocks? in research, providing infrastructure and collaborative support, and enhancing training, education, and career development. Role: Co-Investigator R01NS082432 (Lipton) 02/01/2013-01/31/2018 0.94 calendar months NIH $466,607 Brain injury due to soccer heading and opportunities for its mitigation The purpose of this project is to determine the influence of heading on brain structure and function. 1 R01 HD079951-01A1 (Buyon) 12/01/2014 ? 11/30/2019 0.48 calendar months NIH/NICHD $10,986 (Year 1 direct costs ? Einstein subaward) Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH) The goal of this project is to determine whether hydroxychloroquine use during pregnancy prevents the recurrence of congenital heart block (CHB). Specific Aim 1 is to complete Stage II of the open label Phase II trial, entitled Preventive Approach To Congenital Heart Block with Hydroxychloroquine (PATCH), in pregnant women who have had a previous CHB child. Specific Aim 2 addresses the ophthalmologic safety of HCQ exposure during pregnancy. Role on project: Biostatistician (Consortium site PI) AHRQ (Marantz) 06/01/2014 ? 05/31/2019 1.20 calendar months $500,000 Education and Training Program in Patient Centered Outcomes Research Role: Instructor 1U01CA199221-02 (Gorlick) 7/1/2015 ? 6/30/2020 0.4 calendar months NCI $242,719 Osteosarcoma: Patient Derived Xenograft Preclinical Testing In this proposal a highly informative and representative panel of osteosarcoma tumor samples obtained from patients and grown in immuno-deficient mice will be used to identify novel drugs and drug combinations that may be effective in clinical trials in osteosarcoma patients Role: Biostatistician Lupus Foundation of America (Kim) 10/01/2015 ? 09/30/2016 1.66 calendar months $60,000 An Integrated Analysis of Data from Placebo Groups Participation Multi-Center Clinical Trials for Lupus The goal of this project is to use statistical modeling approaches to identify predictors of disease outcomes in lupus patients randomized to the placebo arms of multiple clinical trials. Role: PI AD-1402-10857 (McKee) 9/1/2015 ? 11/30/2017 0.93 calendar months $20,408 salary support Acupuncture Approaches to Decrease Disparities in Outcomes of Pain Treatment - A Two Arm Comparative Effectiveness Trial This project will compare the effectiveness of group versus individual acupuncture therapy for reducing chronic pain. Role: Biostatistician
NONE
Lupus Foundation of America
NONE
NONE
NONE
NONE
NONE
NONE
- Michael L. Lipton, MD, PhD
(1) Guerbet (2) Bracco
NONE
NONE
(1) American Journal of Neuroimaging, Editorial Board, 2015- (2) Brain Imaging and Behavior, Editorial Board, 2016-
(1) EZ-MAP image processing software
(1) Totally Accessible MRI, Springer, 2008
NONE
(1) Bracco
NONE
NONE
NONE
(1) Philips Medical Systems
(1) NIH - NINDS, R01 NS082432, Principle Investigator, 2013- (2) NIH - NIA, P01 AG003949, Core Leader, 2009- (3) NIH - NICHD, P30 HD071593, Core Leader, 2011-2016 (4) NIH - NIA, R01 AG036921, Co-Investigator, 2011-2016 (5) NIH - NICHD, R01 HL105212, Co-Investigator, 2011-2016 (6) NIH - NIA, R01 AG044007, Co-Investigator, 2013- (7) NIH - NICHD, U54 HD090260, Co-Investigator, 2016-
NONE
(1) The Dana Foundation (2) The Resurrecting Lives Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- From Sutter Health Research (W.F.S.), Walnut Creek, CA; The Gruss Magnetic Resonance Research Center (N.K., C.S.I., T.A.B., M.L.L.), the Departments of Radiology (N.K., C.S.I., T.A.B., M.L.L.), Neurology (R.B.L., M.E.Z.), Epidemiology and Population Health (R.B.L., M.K.), and Psychiatry and Behavioral Sciences (M.L.L.), and The Dominick P. Purpura Department of Neuroscience (M.L.L.), Albert Einstein College of Medicine and Montefiore Medical Center; and Fordham University (M.E.Z.), Bronx, NY.
- Correspondence to Dr. Lipton: Michael.Lipton{at}einstein.yu.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan